Integra Lifesciences Holdings (IART) Retained Earnings (2009 - 2026)

Integra Lifesciences Holdings has disclosed Retained Earnings across 18 years of filings, most recently posting $418.8 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at $418.8 million, up 1837.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $418.8 million (up 1837.43% YoY), and the FY2025 annual result was $423.4 million, up 1635.82% from the prior year.
• Retained Earnings came in at $418.8 million for Q1 2026 at Integra Lifesciences Holdings, down from $423.4 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $946.9 million in Q4 2023 to a low of -$27.6 million in Q4 2024.
• The 5-year median for Retained Earnings is $10.3 million (2022), against an average of $311.7 million.
• Across the five-year window, Retained Earnings soared 12561.69% in 2023 and tumbled 250.64% in 2024, its largest moves.
• Integra Lifesciences Holdings' Retained Earnings stood at $10.3 million in 2022, then soared by 9124.15% to $946.9 million in 2023, then plunged by 102.91% to -$27.6 million in 2024, then jumped by 1635.82% to $423.4 million in 2025, then retreated by 1.09% to $418.8 million in 2026.
• The last three Retained Earnings figures came in at $418.8 million (Q1 2026), $423.4 million (Q4 2025), and $425.1 million (Q3 2025), per Business Quant data.